Mesothelioma drug maker Alfacell looks for buyer
Alfacell, manufacturer of the leading mesothelioma drug ONCONASE, has announced that it has hired financial advisor Oppenheimer & Co. to assist in the company’s “pursuit of available strategic alternatives to enhance shareholder value,” including a possible sale of the company. In a news release dated Sept. 17, Alfacell President Lawrence A. Kenyon says, “We continue to make progress on the completion of our rolling new drug application (NDA) and have undertaken this project in an effort t
Original post by Dave Austin